| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
A Randomized, Noninferiority Trial Comparing ICS + LABA with ICS + LABA + LAMA in Asthma-COPD Overlap (ACO) Treatment: The ACO Treatment with Optimal Medications (ATOMIC) Study
|
Park, So-Young
|
|
|
9 |
3 |
p. 1304-1311.e2
|
artikel
|
| 2 |
As-Needed Versus Regular Use of Fluticasone Furoate Nasal Spray in Patients with Moderate to Severe, Persistent, Perennial Allergic Rhinitis: A Randomized Controlled Trial
|
Thongngarm, Torpong
|
|
|
9 |
3 |
p. 1365-1373.e6
|
artikel
|
| 3 |
A Special Thank-You to Our Reviewers
|
|
|
|
9 |
3 |
p. 1049-1052
|
artikel
|
| 4 |
Asthma Prevalence and Mold Levels in US Northeastern Schools
|
Howard, Evin J.
|
|
|
9 |
3 |
p. 1312-1318
|
artikel
|
| 5 |
Benralizumab as a Steroid-Sparing Treatment Option in Eosinophilic Granulomatosis with Polyangiitis
|
Guntur, Vamsi P.
|
|
|
9 |
3 |
p. 1186-1193.e1
|
artikel
|
| 6 |
Beta-2 Agonists May be Superior to Epinephrine to Relieve Severe Anaphylactic Uterine Contractions
|
D'Astous-Gauthier, Katherine
|
|
|
9 |
3 |
p. 1232-1241
|
artikel
|
| 7 |
Biological treatments in allergy: prescribing patterns and management of hypersensitivity reactions
|
Barakat, Leyla
|
|
|
9 |
3 |
p. 1396-1399.e2
|
artikel
|
| 8 |
Biologics for the Use in Chronic Spontaneous Urticaria: When and Which
|
Maurer, Marcus
|
|
|
9 |
3 |
p. 1067-1078
|
artikel
|
| 9 |
Biologics for Treatment of Atopic Dermatitis: Current Status and Future Prospect
|
Ratchataswan, Thanaporn
|
|
|
9 |
3 |
p. 1053-1065
|
artikel
|
| 10 |
Biologic Therapy in Allergy Practice: A New Era in Treatment Has Begun
|
Wu, Ann Chen
|
|
|
9 |
3 |
p. 1118-1120
|
artikel
|
| 11 |
“Can Do” Versus “Do Do” in Patients with Asthma at First Referral to a Pulmonologist
|
Janssen, Steffi M.J.
|
|
|
9 |
3 |
p. 1278-1284
|
artikel
|
| 12 |
Cardiovascular adverse effects of anti–IL-5/IL-5Rα therapies: A real-world study
|
Quinta, Jean-Baptiste
|
|
|
9 |
3 |
p. 1411-1413
|
artikel
|
| 13 |
Chronic Rhinosinusitis with Nasal Polyps and Asthma
|
Laidlaw, Tanya M.
|
|
|
9 |
3 |
p. 1133-1141
|
artikel
|
| 14 |
Clinical Development of Mepolizumab for the Treatment of Severe Eosinophilic Asthma: On the Path to Personalized Medicine
|
Pavord, Ian D.
|
|
|
9 |
3 |
p. 1121-1132.e7
|
artikel
|
| 15 |
CME Exam: Biologics for the Use in Chronic Spontaneous Urticaria: When and Which
|
|
|
|
9 |
3 |
p. 1079-1080
|
artikel
|
| 16 |
CME Exam: Biologics for Treatment of Atopic Dermatitis: Current Status and Future Prospect
|
|
|
|
9 |
3 |
p. 1066
|
artikel
|
| 17 |
CME Exam: How to Assess Effectiveness of Biologics for Asthma and What Steps to Take When There Is Not Benefit
|
|
|
|
9 |
3 |
p. 1089
|
artikel
|
| 18 |
Continuing Medical Education Calendar
|
|
|
|
9 |
3 |
p. A40-A41
|
artikel
|
| 19 |
Corneal Hydrops Associated with Keratoconus in a Young Girl with Severe Allergic Conjunctivitis
|
Ruiz-Lozano, Raul E.
|
|
|
9 |
3 |
p. 1376-1377
|
artikel
|
| 20 |
Cost-Effectiveness of Biologics for Allergic Diseases
|
Wu, Ann Chen
|
|
|
9 |
3 |
p. 1107-1117.e2
|
artikel
|
| 21 |
Cover 1
|
|
|
|
9 |
3 |
p. OFC
|
artikel
|
| 22 |
Detecting Lesional Granulysin Levels for Rapid Diagnosis of Cytotoxic T lymphocyte–Mediated Bullous Skin Disorders
|
Chen, Chun-Bing
|
|
|
9 |
3 |
p. 1327-1337.e3
|
artikel
|
| 23 |
Dupilumab Improves Asthma and Sinonasal Outcomes in Adults with Moderate to Severe Atopic Dermatitis
|
Boguniewicz, Mark
|
|
|
9 |
3 |
p. 1212-1223.e6
|
artikel
|
| 24 |
Dupilumab Improves Asthma Control and Lung Function in Patients with Insufficient Outcome During Previous Antibody Therapy
|
Mümmler, Carlo
|
|
|
9 |
3 |
p. 1177-1185.e4
|
artikel
|
| 25 |
Editorial Board
|
|
|
|
9 |
3 |
p. A34
|
artikel
|
| 26 |
Effect of α1 antitrypsin deficiency on lung volume decline in severe asthmatic patients undergoing biologic therapy
|
Vianello, Andrea
|
|
|
9 |
3 |
p. 1414-1416
|
artikel
|
| 27 |
Electronic Cigarettes and Their Impact on Allergic Respiratory Diseases: A Work Group Report of the AAAAI Environmental Exposures and Respiratory Health Committee
|
Hernandez, Michelle L.
|
|
|
9 |
3 |
p. 1142-1151
|
artikel
|
| 28 |
Eosinophilia in Asthma Patients Is Protective Against Severe COVID-19 Illness
|
Ferastraoaru, Denisa
|
|
|
9 |
3 |
p. 1152-1162.e3
|
artikel
|
| 29 |
Eosinophil-mast cell interaction: Mepolizumab leads to a reduction of clinical symptoms and serum tryptase in a patient with eosinophilic asthma and idiopathic mast cell activation
|
Guillet, Carole
|
|
|
9 |
3 |
p. 1393-1395.e1
|
artikel
|
| 30 |
Factors Associated with Nonadherence to Inhaled Corticosteroids for Asthma During Pregnancy
|
Robijn, Annelies L.
|
|
|
9 |
3 |
p. 1242-1252.e1
|
artikel
|
| 31 |
False tolerant food challenges in children with food protein–induced enterocolitis syndrome
|
Weisz, Gabriella
|
|
|
9 |
3 |
p. 1418
|
artikel
|
| 32 |
First Real-World Effectiveness Analysis of Preschool Peanut Oral Immunotherapy
|
Soller, Lianne
|
|
|
9 |
3 |
p. 1349-1356.e1
|
artikel
|
| 33 |
Habit Cough in Adults
|
Weinberger, Miles
|
|
|
9 |
3 |
p. 1417
|
artikel
|
| 34 |
High levels of anxiety during the COVID-19 pandemic as a risk factor of clinical worsening in patients with severe asthma
|
Lacwik, Piotr
|
|
|
9 |
3 |
p. 1381-1383
|
artikel
|
| 35 |
How to Assess Effectiveness of Biologics for Asthma and What Steps to Take When There Is Not Benefit
|
Pepper, Amber N.
|
|
|
9 |
3 |
p. 1081-1088
|
artikel
|
| 36 |
Improved FcεRI-Mediated CD203c Basophil Responsiveness Reflects Rapid Responses to Omalizumab in Chronic Spontaneous Urticaria
|
Oda, Yoshiko
|
|
|
9 |
3 |
p. 1166-1176.e8
|
artikel
|
| 37 |
Increased disinfectant use among adults with asthma in the era of COVID-19
|
Eldeirawi, Kamal
|
|
|
9 |
3 |
p. 1378-1380.e2
|
artikel
|
| 38 |
Information for Readers
|
|
|
|
9 |
3 |
p. A36
|
artikel
|
| 39 |
Is It Time to Offer Peanut Oral Immunotherapy to Toddlers?
|
Burris, Amy D.
|
|
|
9 |
3 |
p. 1357-1358
|
artikel
|
| 40 |
Longitudinal Outcomes of Severe Asthma: Real-World Evidence of Multidimensional Analyses
|
Lee, Youngsoo
|
|
|
9 |
3 |
p. 1285-1294.e6
|
artikel
|
| 41 |
Long-term follow-up and treatment outcomes of conjunctivitis during dupilumab treatment in patients with moderate-to-severe atopic dermatitis
|
Achten, Roselie
|
|
|
9 |
3 |
p. 1389-1392.e2
|
artikel
|
| 42 |
Long-Term Therapy Response to Anti–IL-5 Biologics in Severe Asthma—A Real-Life Evaluation
|
Eger, Katrien
|
|
|
9 |
3 |
p. 1194-1200
|
artikel
|
| 43 |
Maternal Depressive Symptoms, Lung Function, and Severe Asthma Exacerbations in Puerto Rican Children
|
Stevens, Erica L.
|
|
|
9 |
3 |
p. 1319-1326.e3
|
artikel
|
| 44 |
Mepolizumab does not prevent all aspirin-induced reactions in patients with aspirin-exacerbated respiratory disease: A case series
|
Martin, Hannah
|
|
|
9 |
3 |
p. 1384-1385
|
artikel
|
| 45 |
Mepolizumab 100 mg in severe asthmatic patients with EGPA in remission phase
|
Caminati, Marco
|
|
|
9 |
3 |
p. 1386-1388
|
artikel
|
| 46 |
New aspects of fundamental pathology and environmental control: Important issues in allergic bronchopulmonary mycosis
|
Ohkura, Noriyuki
|
|
|
9 |
3 |
p. 1420
|
artikel
|
| 47 |
Olfactory Function Is Impaired in Patients with Mastocytosis
|
Masala, Carla
|
|
|
9 |
3 |
p. 1359-1364
|
artikel
|
| 48 |
Omalizumab improves perceived stress, anxiety, and depression in chronic spontaneous urticaria
|
Patella, Vincenzo
|
|
|
9 |
3 |
p. 1402-1404
|
artikel
|
| 49 |
“Omalizumab plus”: Combining omalizumab with immunosuppression for treatment of refractory chronic urticaria: A multicenter UK series
|
Rutkowski, Krzysztof
|
|
|
9 |
3 |
p. 1400-1401.e2
|
artikel
|
| 50 |
Optimizing omalizumab dosing in severe asthma—the exploration of therapeutic drug monitoring
|
Kroes, Johannes Anthon
|
|
|
9 |
3 |
p. 1408-1410.e1
|
artikel
|
| 51 |
Original Article Highlights From This Issue
|
|
|
|
9 |
3 |
p. A28-A33
|
artikel
|
| 52 |
Penicillin Allergy Assessment in Pregnancy: Safety and Impact on Antibiotic Use
|
Wolfson, Anna R.
|
|
|
9 |
3 |
p. 1338-1346
|
artikel
|
| 53 |
Penilloate and penicilloate concentrations in practical guidance recommendations
|
Maroto, Enric
|
|
|
9 |
3 |
p. 1418-1419
|
artikel
|
| 54 |
Possible Protective Effect of Omalizumab on Lung Function Decline in Patients Experiencing Asthma Exacerbations
|
Busse, William W.
|
|
|
9 |
3 |
p. 1201-1211
|
artikel
|
| 55 |
Practice Notes from the AAAI
|
|
|
|
9 |
3 |
p. A37-A39
|
artikel
|
| 56 |
Predicting Who Will Stop Medications During Pregnancy: A Complex Issue
|
Wangberg, Hannah
|
|
|
9 |
3 |
p. 1253-1254
|
artikel
|
| 57 |
Prioritizing Treatable Traits in Airways Disease
|
Hew, Mark
|
|
|
9 |
3 |
p. 1265-1266
|
artikel
|
| 58 |
Reply to “New aspects of fundamental pathology and environmental control: Important issues in allergic bronchopulmonary mycosis”
|
Oguma, Tsuyoshi
|
|
|
9 |
3 |
p. 1420-1421
|
artikel
|
| 59 |
Reply to “Penilloate and penicilloate concentrations in practical guidance recommendations”
|
Romano, Antonino
|
|
|
9 |
3 |
p. 1419-1420
|
artikel
|
| 60 |
Successful pregnancy in the setting of eosinophil depletion by benralizumab
|
Manetz, Scott
|
|
|
9 |
3 |
p. 1405-1407.e3
|
artikel
|
| 61 |
Table of Contents
|
|
|
|
9 |
3 |
p. A10-A11, A16-A21, A26-A27
|
artikel
|
| 62 |
The Clinical Course of Asthma After Withdrawal of Inhaled Corticosteroids
|
Han, Dong-Woo
|
|
|
9 |
3 |
p. 1295-1303.e3
|
artikel
|
| 63 |
The Debate: Regular Versus As-Needed Use of Intranasal Corticosteroids for a Patient-Centered Approach
|
Bousquet, Jean
|
|
|
9 |
3 |
p. 1374-1375
|
artikel
|
| 64 |
The Importance of Penicillin Allergy Evaluation in Pregnant Women
|
Iammatteo, Melissa
|
|
|
9 |
3 |
p. 1347-1348
|
artikel
|
| 65 |
The Prevalence of Subtypes of Type 2 Inflammation in an Unselected Population of Patients with Severe Asthma
|
Frøssing, Laurits
|
|
|
9 |
3 |
p. 1267-1275
|
artikel
|
| 66 |
The Relationship of Asthma Biologics to Remission for Asthma
|
Menzies-Gow, Andrew
|
|
|
9 |
3 |
p. 1090-1098
|
artikel
|
| 67 |
The Role of Biologics in Chronic Rhinosinusitis with Nasal Polyps
|
Bachert, Claus
|
|
|
9 |
3 |
p. 1099-1106
|
artikel
|
| 68 |
Treatable Traits That Predict Health Status and Treatment Response in Airway Disease
|
Hiles, Sarah A.
|
|
|
9 |
3 |
p. 1255-1264.e2
|
artikel
|
| 69 |
Type 2 Asthma Inflammation and COVID-19: A Double Edged Sword
|
Lipworth, Brian
|
|
|
9 |
3 |
p. 1163-1165
|
artikel
|
| 70 |
Type 2 Biomarkers in Asthma: Yet Another Reflection of Heterogeneity
|
Lugogo, Njira L.
|
|
|
9 |
3 |
p. 1276-1277
|
artikel
|
| 71 |
Variability in Blood Eosinophil Counts in Patients with Eosinophilic Asthma
|
Corren, Jonathan
|
|
|
9 |
3 |
p. 1224-1231.e9
|
artikel
|
Tijdschrift beschrijving